Taro Pharmaceutical Industries Ltd

TARO:NYSE
RT Quote | NYSE | USD
Last | 01/15/21 EST
77.69quote price arrow up+2.13 (+2.82%)
Volume
18,035
52 week range
53.95 - 86.86

...

Loading . . .

KEY STATS

  • Open75.84
  • Day High77.95
  • Day Low75.50
  • Prev Close75.56
  • 52 Week High86.86
  • 52 Week High Date01/16/20
  • 52 Week Low53.95
  • 52 Week Low Date09/29/20
  • Market Cap2,972.42M
  • Shares Out38.26M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta1.04
  • 1 Year % Change-9.75

RATIOS/PROFITABILITY

  • EPS (TTM)-7.02
  • P/E (TTM)-11.07
  • Fwd P/E (NTM)20.18
  • EBITDA (MRQ)208.38M
  • ROE (MRQ)-14.27%
  • Revenue (MRQ)583.10M
  • Gross Margin (MRQ)58.81%
  • Net Margin (MRQ)-48.50%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date02/01/2021
  • Ex Div Date12/10/2018
  • Div Amount12.8601
  • Split Date-
  • Split Factor-

Latest Taro Pharmaceutical Industries Ltd News

There is no recent news for this security.

Latest TARO News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. The Company markets over 200 pharmaceutical products in over 25 countries. The Company's owned product brands include Rokacet, with generic names, such as acetaminophen, codeine and caffeine; Topicort...
Dilip Shanghvi
Chairman
Abhay Gandhi
Vice Chairman
Uday Baldota
Chief Executive Officer
Daphne Huang
Chief Financial Officer
Erik Zwicker
Vice President
Address
14 Hakitor Street,
PO Box 10347
Haifa
2624761
Israel